Clinical Trial: Phase I Trial of HHK101 in Patients With Schizophrenia

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07815210) titled 'Phase I Trial of HHK101 in Patients With Schizophrenia' on Sept. 07.

Brief Summary: This study aims to learn how the study drug is absorbed by the body, check for possible side effects, and see if the drug may help improve symptoms in patients with schizophrenia.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Schizophrenia

Intervention: DRUG: HHK101

A single intramuscular injection of HHK101-Dose 1

DRUG: HHK101

A single intramuscular injection of HHK101-Dose 2

DRUG: HHK101

A single intramuscular injection of HHK101-Dose 3

DRUG: HHK101

A single intramuscular injection of HHK101-Dose 4

DRUG: HHK101

A ...